Dos proyectos GETECCU – ENEIDA han sido publicados en la revista Alimentary Pharmacology & Therapeutics.
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry. Dra. M. Iborra. Enlace a PUBMED
Increased risk of thiopurine-related adverse events in elderly patients with inflammatory bowel disease. Dra. M. Calafat. (enlace disponible próximamente)